anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
BenevolentAI · pitchdeck

BenevolentAI | Investor Presentation Deck | 31 slides

31 pages · 5 arc beats · 3 loops

Pitchdeck Download JSON
Unlock

BenevolentAI | Investor Presentation Deck | 31 slides

BenevolentAI · 2024-09
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 5 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem (Identify pain) 1 slides 100% 1/1 slides 100% 1/1 slides · 10 hits
— 0/1 slides
100% 1/1 slides · 2 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Agitate (Make it worse) 1 slides 100% 1/1 slides 100% 1/1 slides · 8 hits
— 0/1 slides
100% 1/1 slides · 2 hits 100% 1/1 slides 100% 1/1 slides
— 0/1 slides
Solution (Provide relief) 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides
Financials 1 slides 100% 1/1 slides 100% 1/1 slides · 9 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

31
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
The slide uses a non-linear, interconnected circular node design to represent a timeline.show_traction
Open slide detail
04
The slide combines team bios with business model and partnership validation.other
Open slide detail
05
Uses a structured layout to categorize problems into three pillars: cost/risk, time, and efficacy.frame_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
06
inspire_vision
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
07
The slide uses a split-screen layout to contrast partnership-based revenue with internal pipeline development.present_solution
Open slide detail
08
The slide uses a process flow diagram to illustrate the drug discovery pipeline.present_solution
Open slide detail
09
The slide uses a circular arrow graphic to represent a feedback loop between in-silico and in-vitro processes.present_solution
Open slide detail
10
The slide uses a 'How we did it' process flow at the bottom to explain the underlying methodology.show_traction
Open slide detail
11
The slide uses a timeline on the left and a summary of partnership terms on the right.show_traction
Open slide detail
12
show_traction
Open slide detail
13
The slide uses a Gantt-style chart to show the progress of different drug programs. It distinguishes between proprietary (teal) and partner (yellow) pipelines.show_traction
Open slide detail
14
Includes two process diagrams illustrating the Benevolent Platform's role and the experimental validation process.present_solution
Open slide detail
15
The slide uses a table to demonstrate market validation for early-stage IBD assets.cite_precedent
Open slide detailBeat · Market Size
16
The slide uses a causal chain logic to connect market deal activity and clinical unmet needs to the value proposition of the drug.argue_timing
Open slide detailLoop · Why Now
17
The slide uses a two-row structure to contrast 'Collaborations' and 'Out licensing' business models.show_traction
Open slide detail
18
The slide uses a grid layout to present three distinct partner endorsements with associated logos and investment figures.cite_precedent
Open slide detail
19
The slide uses a grid layout to present financial KPIs.summarize
Open slide detailBeat · Financials
20
The slide uses a vertical list format to present the investment thesis.summarize
Open slide detail
21
appendix
Open slide detail
22
Includes corporate structure details, shareholder list, and headshots of leadership.other
Open slide detail
23
Includes a reference to Eroom's law, which describes the observation that drug discovery is becoming slower and more expensive over time.frame_problem
Open slide detailBeat · Agitate (Make it worse)
24
The slide uses a split-screen approach to contrast two distinct value drivers: cost reduction and success rate improvement.present_solution
Open slide detail
25
The slide uses a table format to demonstrate differentiation and market potential for five specific pipeline assets.compare_peers
Open slide detail
26
The slide outlines a standard clinical trial structure (SAD, Food Effect, MAD) and highlights the competitive advantage of a clean safety profile compared to hianalyze_data
Open slide detail
27
The slide emphasizes the absence of CNS-associated adverse events, which is a key differentiator for this PDE10 inhibitor.show_traction
Open slide detail
28
The slide uses a combination of text, scientific charts (dose-response curves), and a process diagram to validate the drug's mechanism.show_traction
Open slide detail
29
The slide uses a honeycomb/network diagram to represent data integration and processing.present_solution
Open slide detail
30
The slide uses a process flow diagram to map specific technical capabilities to stages of drug discovery.present_solution
Open slide detail
31
The slide uses a three-column layout to categorize value drivers: proprietary pipeline, partnerships, and future growth.show_traction
Open slide detail